We are dedicated to delivering holistic and seamless legal services tailored to the unique needs of the medical and pharmaceutical sectors. We extend our expertise to a diverse clientele, including enterprises, research and development institutions, and investors, fostering a collaborative approach to legal counsel. We also actively contribute to the advancement of the medical and pharmaceutical industries and strive to be a driving force for broader societal progress.
Our medical and pharmaceutical practice is extensive, covering a wide range of areas including but not limited to drug research and development, production, sales, medical device innovation and sales, and the delivery of medical services. With cross-disciplinary expertise, we offer full-spectrum legal support. Our professional legal knowledge and industry insights enable us to provide a complete range of legal services, from intellectual property protection, data protection and compliance, to clinical trial management and drug registration applications, ensuring our clients gain a competitive edge in a highly competitive market.
We are committed to tackling the legal challenges faced by clients in the medical and pharmaceutical fields and assist them in establishing systems and procedures that strictly comply with legal regulations and industry standards. This proactive approach is pivotal in effectively preventing and mitigating potential legal risks, providing a secure foundation for our clients’ operations.
Furthermore, we extend our legal expertise to the facilitation of commercial transactions and strategic planning initiatives. Our comprehensive support is designed to not only guide our clients through complex business deals but also to help them achieve their strategic business objectives and realize their development plans.
-
Mergers and acquisitions, restructuring, reform, investment, and financing of pharmaceutical companies
-
Prevention of legal risks such as commercial bribery in pharmaceutical companies
-
Transfer of drug varieties, feasibility studies, and risk prevention for pharmaceutical companies
-
Drug infringement disputes
-
Planning, establishment, entrustment, reform, mergers and acquisitions, and financing of medical institutions
-
Risk management of medical institutions, and rights protection for medical torts
-
Registration and legal risk prevention for medical device companies
-
Mergers and acquisitions, restructuring, reform, investment, and financing of medical device companies
-
Medical device infringement disputes
-
Investment and financing, equipment financial leasing for medical device companies
-
Intellectual property right protection and management for medical product companies
-
Resolution of sales disputes and controversies of medical products
-
Anti-unfair competition in the pharmaceutical industry
-
Labor disputes within pharmaceutical companies
-
Other daily legal matters of pharmaceutical companies
Get to know our team of professionals
-
Xianhao GuoManaging PartnerShanghai
-
Claire BaiSenior PartnerShanghai
-
Adela JiPartnerShanghai
-
Liwen WangPartnerShanghai
-
Haiyan MaoPartnerShanghai
-
Ganyu DingSenior AssociateShanghai
-
Jing WangSenior AssociateShanghai
-
Jin WuSenior AssociateShanghai
-
Frank LuSenior AssociateShanghai
-
Xiaoxin ZhangSenior AssociateShanghai
-
Yunru GuoAssociateShanghai
-
Dandan WangAssociateWuhu
-
Yiwen XieAssociateShanghai
-
Qianqian LiuAssociateShanghai
-
Jie QingAssociateChengdu
-
Qianqian WuAssociateWuhu
-
Wenfang DongAssociateWuhu
Related News
-
Explore | The mid-year partner meeting of Dehehantong Law Offices was successfully concluded2024-07-24
-
Discussion on the application of “Protection of Consumer Rights and Interests”in medical and American disputes2024-06-25
-
Dehe Shanghai Non-performing Assets and Restructuring Business Committee successfully held the theme lecture "The Impact of the New Company Law on Insolvency Business"2024-06-25
-
The "Sino-US Dispute Resolution Litigation and Arbitration" seminar was successfully held in Dehehantong2024-01-19
-
The first meeting of the National Management Committee of Dehehantong in 2024 was successfully concluded in Macao2024-01-17